Replies to post #559929 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for asking! Explore the links below for a good overview of some interesting and relevant current developments:

Skip to about 6:30 of the video to hear Dr. Toms also briefly highlight the pembrolizumab combo study at UCLA!

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847



https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/

Don’t miss this interview later this week:

YouTube Livestream with Wes Christian confirmed: Wed 12.30pm EST on the War on Naked Short Selling #NakedShorts - And to discuss the big news being announced tomorrow. Livestream here: https://t.co/zY79HJLBvM

— Roger James Hamilton (@rogerhamilton) January 16, 2023

In the previous interview, Mr. Christian mentioned Northwest Biotherapeutics three times: NWBO is cited as a specific example at timestamp 14:30 of the video. NWBO is also mentioned at 8:17 and again at 34:08.

https://www.youtube.com/rogerhamiltontv

https://christianlevinelaw.com/lawyer/james-wesley-christian/

[Roman516]

The JAMA Oncology indicated that the data was in fact true and legitimate, and we all know this to be true. In addition, we all know that the OS data was also better than expected.
Last, we all know that there are more doctors, scientists, and professionals are in agreement that the data is true and worth for NWBO to go forward. This is further proof that DCVax-L works and should be approved soon, weeks not months or years. All the best!

[biosectinvestor]

Peer review does not just involve the data that was delivered. There are back and forth discussions, questions and comments addressed. Presuming that JAMA incompetently did its review is not just baseless, it’s bizarre.